Evidence map›Paper›PMID 24671947›Full record

ArticleOpen biology2014

Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni.

Patcharin Siringan, Phillippa L Connerton, Nicola J Cummings, Ian F Connerton

Abstract read
In one paragraph

Article in Open biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Microorganisms · 2025
    Article
  5. Aerotolerancy ofPathogens (Basel, Switzerland) · 2024
    Review
  6. Symbiosis of a lytic bacteriophage andApplied and environmental microbiology · 2024
    Article
  7. Article
  8. Phage-Based Biosanitation Strategies for Minimizing PersistentAnimals : an open access journal from MDPI · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Bacteriophages and their potential for treatment of gastrointestinal diseases.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Phage Biocontrol of Campylobacter: A One Health Approach.Current topics in microbiology and immunology · 2021
    Review
  20. Application of Bacteriophages to LimitFrontiers in microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patcharin SiringanDivision of Food Sciences, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leicestershire LE12 5RD, UK.
Phillippa L Connerton
Nicola J Cummings
Ian F Connerton

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Members of the genus Campylobacter are frequently responsible for human enteric disease, often through consumption of contaminated poultry products. Bacteriophages are viruses that have the potential to control pathogenic bacteria, but understanding their complex life cycles is key to their successful exploitation. Treatment of Campylobacter jejuni biofilms with bacteriophages led to the discovery that phages had established a relationship with their hosts typical of the carrier state life cycle (CSLC), where bacteria and bacteriophages remain associated in equilibrium. Significant phenotypic changes include improved aerotolerance under nutrient-limited conditions that would confer an advantage to survive in extra-intestinal environments, but a lack in motility eliminated their ability to colonize chickens. Under these circumstances, phages can remain associated with a compatible host and continue to produce free virions to prospect for new hosts. Moreover, we demonstrate that CSLC host bacteria can act as expendable vehicles for the delivery of bacteriophages to new host bacteria within pre-colonized chickens. The CSLC represents an important phase in the ecology of Campylobacter bacteriophage.

Indexed as

AnimalsAntibodies, NeutralizingBacteriophagesBiofilmsCampylobacter jejuniChickensDNA, ViralLife Cycle StagesAntibodies, NeutralizingDNA, ViralbacteriophagesCampylobacterCampylobacter jejunicarrier state life cyclephage therapy

Identifiers

PMID24671947
PMCPMC3971406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.